These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14612151)

  • 1. Na+ and the substrate permeation pathway in dopamine transporters.
    Chen N; Reith ME
    Eur J Pharmacol; 2003 Oct; 479(1-3):213-21. PubMed ID: 14612151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
    Li LB; Cui XN; Reith MA
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):303-11. PubMed ID: 11919655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na+ stimulates binding of dopamine to the dopamine transporter in cells but not in cell-free preparations.
    Chen N; Rickey J; Reith ME
    J Neurochem; 2003 Aug; 86(3):678-86. PubMed ID: 12859681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of cations and anions with the binding of uptake blockers to the dopamine transporter.
    Bonnet JJ
    Eur J Pharmacol; 2003 Oct; 479(1-3):199-212. PubMed ID: 14612150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine.
    Chen N; Zhen J; Reith ME
    J Neurochem; 2004 May; 89(4):853-64. PubMed ID: 15140185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between dopamine and its transporter: role of intracellular sodium ions and membrane potential.
    Chen N; Reith ME
    J Neurochem; 2004 May; 89(3):750-65. PubMed ID: 15086531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride.
    Borre L; Andreassen TF; Shi L; Weinstein H; Gether U
    J Biol Chem; 2014 Sep; 289(37):25764-73. PubMed ID: 25063810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of disruption of secondary binding site S2 on dopamine transporter function.
    Zhen J; Reith ME
    J Neurochem; 2016 Sep; 138(5):694-9. PubMed ID: 27315582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing dopamine transporter structure and function by Zn2+-site engineering.
    Loland CJ; Norgaard-Nielsen K; Gether U
    Eur J Pharmacol; 2003 Oct; 479(1-3):187-97. PubMed ID: 14612149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can be learned from studies of multisubstrate mechanisms of neuronal dopamine transport?
    Schenk JO; George SE; Schumacher PD
    Eur J Pharmacol; 2003 Oct; 479(1-3):223-8. PubMed ID: 14612152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural domains of chimeric dopamine-noradrenaline human transporters involved in the Na(+)- and Cl(-)-dependence of dopamine transport.
    Syringas M; Janin F; Mezghanni S; Giros B; Costentin J; Bonnet JJ
    Mol Pharmacol; 2000 Dec; 58(6):1404-11. PubMed ID: 11093780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition.
    Meiergerd SM; McElvain JS; Schenk JO
    Biochem Pharmacol; 1994 Apr; 47(9):1627-34. PubMed ID: 8185677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains.
    Lin Z; Wang W; Uhl GR
    Mol Pharmacol; 2000 Dec; 58(6):1581-92. PubMed ID: 11093799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter.
    Zhen J; Maiti S; Chen N; Dutta AK; Reith ME
    Eur J Pharmacol; 2004 Dec; 506(1):17-26. PubMed ID: 15588620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for substrate recognition by the human dopamine transporter.
    Appell M; Berfield JL; Wang LC; Dunn WJ; Chen N; Reith ME
    Biochem Pharmacol; 2004 Jan; 67(2):293-302. PubMed ID: 14698042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
    Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
    J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
    Chen N; Trowbridge CG; Justice JB
    J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of methylphenidate and benztropine with the dopamine transporter is different than other substrates and ligands.
    Dar DE; Mayo C; Uhl GR
    Biochem Pharmacol; 2005 Aug; 70(3):461-9. PubMed ID: 15950948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.